SENSIMED
Lausanne, Vaud, Switzerland
About SENSIMED
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.4M
- Funding stage: M&A
- Last round: Series C (Jul 2013)
- Website: sensimed.ch
- Phone: 41 21 621 91 91
Industries & Categories
Emergency Medicine, Health Care, Medical, Medical Device, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/sensimed-2501205 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.